Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001493152-23-016636
| Metric | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|
| Revenue | $8.73M | $9.75M | $4.74M |
| Net Income | -$7.48M | $5.56M | -$3.53M |
| EPS Diluted | -$5.60 | $0.32 | -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end
